ArriVent BioPharma, Inc.

A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.

AVBP | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 18 CAMPUS BLVD., NEWTOWN SQUARE
Website:: https://arrivent.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical company dedicated to identifying, developing, and commercializing differentiated medicines for patients with difficult-to-treat diseases, with an initial focus on oncology. The company's strategy centers on forging strategic partnerships to in-license and accelerate the global development of promising drug candidates. Its pipeline is led by its lead development candidate, firmonertinib, an investigational cancer therapeutic, and includes other novel oncology treatments such as next-generation antibody-drug conjugates. ArriVent leverages its team's extensive drug development and regulatory expertise to advance its portfolio and address significant unmet medical needs for global patient populations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ArriVent BioPharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ArriVent BioPharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ArriVent BioPharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
BioArctic Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.	Sweden	BIOA
BioAtla, Inc. Developing safer, conditionally active antibody therapies for solid tumor cancers.	United States of America	BCAB
BioCardia, Inc. Developing regenerative cell therapies for cardiovascular and pulmonary diseases.	United States of America	BCDA
Bioceltix S.A. Developing 'off-the-shelf' stem cell therapies for diseases in companion animals.	Poland	BCX
BIOCRYST PHARMACEUTICALS INC Develops oral small-molecule drugs for rare diseases like hereditary angioedema.	United States of America	BCRX
Biodexa Pharmaceuticals Plc Develops treatments for rare diseases, diabetes, and cancer using proprietary drug delivery tech.	United States of America	BDRX
Biofarm S.A. A top domestic manufacturer of pharmaceuticals, supplements, and soft gelatin capsules.	Romania	BIO
Biofrontera AG Biopharma firm specializing in photodynamic therapy for dermatological conditions like actinic keratosis.	Germany	B8F
Biofrontera Inc. Biopharma firm commercializing photodynamic therapy & antibiotics for skin conditions.	United States of America	BFRI
BioGaia Develops and commercializes clinically proven probiotics for digestive health across all life stages.	Sweden	BIOG